Methotrexate Tablet
Product Images NDC 51079-670

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 51079-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate 2.5 mg Tablets Unit Carton Label (Image 01)

Chemical structure of methotrexate showing its molecular arrangement with rings, amino groups, and carboxylate groups as part of the compound's detailed chemical formula.*

FDA Label Image

Unit Carton (Image 02)

Methotrexate Tablets USP 2.5 mg oral tablets by Mylan Pharmaceutical Inc. The label shows a round, peach-colored tablet imprinted with 'M 14'. Packaging indicates a count of 20 tablets (2 bottles of 10). The label includes a caution for cytotoxicity, storage instructions at controlled room temperature, and a barcode. Mylan Institutional Inc. is the labeler.*

FDA Label Image

Image 03

Packaging label for Methotrexate 2.5 mg oral tablets in a unit-dose package by Mylan Institutional Inc. The blue package includes warnings about non-child-resistant packaging, institutional use, and storage instructions. It displays the Mylan logo and distributor information, with a label window showing a QR code and placeholder text for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.